Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient.
Magliano G, Cuccaro A, d'Alo' F, Maiolo E, Bellesi S, Hohaus S, Bacigalupo A, Pagano L. Magliano G, et al. Among authors: bacigalupo a. Mediterr J Hematol Infect Dis. 2021 Sep 1;13(1):e2021054. doi: 10.4084/MJHID.2021.054. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34527206 Free PMC article. No abstract available.
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.
Autore F, Chiusolo P, Sorà F, Giammarco S, Laurenti L, Innocenti I, Metafuni E, Piccirillo N, Pagano L, Bacigalupo A, Leone G, Sica S. Autore F, et al. Among authors: bacigalupo a. Leuk Lymphoma. 2019 May;60(5):1328-1330. doi: 10.1080/10428194.2018.1522436. Epub 2018 Dec 11. Leuk Lymphoma. 2019. PMID: 30526180 No abstract available.
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT.
Pagano L, Maraglino AME, Fianchi L, Criscuolo M, Rossi E, Za T, Chiusolo P, Bonanni M, Dragonetti G, Bacigalupo A, Sica S, De Stefano V. Pagano L, et al. Among authors: bacigalupo a. Ann Hematol. 2020 Jan;99(1):207-209. doi: 10.1007/s00277-019-03885-7. Epub 2019 Dec 12. Ann Hematol. 2020. PMID: 31832752 No abstract available.
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma.
Galli E, Sorà F, Hohaus S, Bellesi S, Autore F, Metafuni E, Innocenti I, Marra J, Fresa A, Limongiello MA, Giammarco S, Leccisotti L, Guarneri A, Chiusolo P, Laurenti L, Teofili L, Piccirillo N, Bacigalupo A, Sica S. Galli E, et al. Among authors: bacigalupo a. Bone Marrow Transplant. 2022 May;57(5):837-839. doi: 10.1038/s41409-022-01632-7. Epub 2022 Mar 8. Bone Marrow Transplant. 2022. PMID: 35260803 No abstract available.
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients.
Chiusolo P, Metafuni E, Minnella G, Giammarco S, Bellesi S, Rossi M, Sorà F, Limongiello MA, Frioni F, Piccirillo N, Bianchi M, Valentini CG, Teofili L, Sica S, Bacigalupo A. Chiusolo P, et al. Among authors: bacigalupo a. Front Oncol. 2022 Aug 31;12:994366. doi: 10.3389/fonc.2022.994366. eCollection 2022. Front Oncol. 2022. PMID: 36119469 Free PMC article.
838 results